VRXA · Veraxa Biotech AG - Post de-SPAC · Insider Trading
Market Cap
$199.39M
Shares
141.41M
Volume · Oct 5
154.08K
Avg daily vol (3M)
393.01K
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
84
Net buyers
+2
Net shares bought
0.04%
Net buy value
+$82,650
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-08-27 | Baumann Oliver Rolf |
Director |
Buy↑
Filing footnotes — Ordinary Shares (Indirect)
The reported securities are held by Akira Holding AG. The reporting person may be deemed to beneficially own such securities by virtue of their relationship with Akira Holding AG. |
Ordinary Shares
(I)
|
50,000 |
| 2026-08-27 | Antz Christoph Rudiger |
Director, Chief Executive Officer |
Buy↑
|
Ordinary Shares
|
5,000 |
Legend
Buy — open-market purchase
Sell — open-market sale
↑ Shares acquired
↓ Shares disposed (gift, conversion, tax…)
Showing 1–2 of 2 transactions